Tag Archives: gsk

GSK/NIH Ebola Vaccine Trials at Oxford Yield Positive Results, What Next?

GSK/NIH Ebola vaccine clinical trials by Oxford University showed that the vaccine has an acceptable safety profile at the doses tested, and is able to generate an immune response. “The vaccine was well tolerated. Its safety profile is pretty much as we had hoped,” said Professor Adrian Hill of the Jenner Institute at Oxford University, who led the trial. This ...

Read More »

ChAd3 Experimental Ebola Vaccine Safe Though in Trial Stage, say US Researchers

An experimental vaccine, ChAd3, to prevent Ebola virus disease has been found to be well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial, US researchers┬ásaid. Mzapp is another vaccine under trials. The trials were conducted at US National Institutes of Health’s clinical centre in Bethesda, Maryland after they were ...

Read More »